10x Genomics Scheduled to Release Financial Results Soon
10x Genomics, Inc. (NASDAQ: TXG), widely recognized as a leader in the fields of single cell and spatial biology, has announced its plans to reveal the financial results for its fourth quarter and the entire year of 2025. This announcement is expected to take place after the market closes on Thursday, February 12, 2026.
Engagement with Investors
Following the release of its financial results, 10x Genomics will host a public conference call and live webcast. This event is slated to begin at 1:30 PM Pacific Time, which corresponds to 4:30 PM Eastern Time. This call is an excellent opportunity for analysts and investors alike to engage with the company's executive team. They will discuss the financial outcomes, recent business developments, and their outlook for the future. Investors are encouraged to tune in and gain insights into the company’s strategic direction.
Accessing the Results
Details regarding the financial results will be accessible on the 10x Genomics website before the conference call takes place. This ensures that interested parties have all the relevant information at their fingertips. The live webcast will also be available for replay for a minimum of 45 days after the event, providing flexibility for those unable to attend the live presentation.
About 10x Genomics
10x Genomics is committed to revolutionizing the life sciences landscape through advanced technology. They design and manufacture cutting-edge products geared towards furthering biological research and improving human health. Their comprehensive suite encompasses instruments, consumables, and software tailored for single-cell and spatial biology studies.
Driving Scientific Discovery
The innovations developed by 10x Genomics equip researchers and biopharmaceutical companies with the tools they need to decipher complex biological systems. This level of understanding is influential as it drives breakthroughs in diverse areas such as oncology, immunology, and neuroscience. The impact of their work helps transform our comprehension of health and disease, paving the way for future medical advancements.
Connecting with 10x Genomics
10x Genomics invites everyone to learn more about their work by visiting their official website. Here, potential clients and partners can discover detailed information about their research solutions and how they can contribute to advancing the field of life sciences. The company is also active on various social media platforms, allowing individuals to connect and engage with their latest updates and innovations.
Public Disclosure Practices
The company maintains transparency through a variety of channels. 10x Genomics utilizes filings with the Securities and Exchange Commission, its official website, and social media for disclosing essential information to the public. This approach ensures that stakeholders remain informed about significant developments that could impact their investment decisions.
Frequently Asked Questions
When is the financial results announcement for 10x Genomics?
The financial results for 10x Genomics will be reported after market close on February 12, 2026.
What time will the investor call occur?
The call will start at 1:30 PM Pacific Time / 4:30 PM Eastern Time on the same day as the announcement.
How can I access the webcast?
The webcast can be accessed via the 'Investors' section of the 10x Genomics website and will be available for replay afterward.
What are the main offerings of 10x Genomics?
10x Genomics specializes in single-cell and spatial biology products which include instruments, consumables, and software aimed at facilitating innovative biological research.
Where can I find more information about 10x Genomics?
Additional information can be found on the company’s official website, as well as through their social media channels.